ArticleJournal of community hospital internal medicine perspectives2026
Non-alcoholic Wernicke Encephalopathy With Atypical Cortical Involvement on MRI: A Case Report.
Article in Journal of community hospital internal medicine perspectives, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While Wernicke encephalopathy (WE) is well-recognized as a condition most frequently associated with chronic excessive alcohol consumption, non-alcoholic WE (NAWE) remain underrecognized despite their clinical importance. An 85-year-old nursing home resident was brought to the Emergency Department (ED) with impaired consciousness. She had been taking furosemide 40 mg and spironolactone 25 mg daily for chronic heart failure for five months prior to presentation. One month before admission, she began receiving parenteral nutrition without thiamine due to poor oral intake accompanied by vomiting. On arrival, her Glasgow Coma Scale score was 3, exhibiting flaccid quadriplegia and absent deep tendon and oculocephalic reflexes. Brain MRI demonstrated hyperintensities in the peri-central sulcus cortex as well as typical WE-related regions, including the periaqueductal gray and bilateral medial thalami, on diffusion-weighted imaging (DWI) and T2-weighted imaging. Intravenous high-dose thiamine therapy was initiated based on a clinical diagnosis of WE, subsequently confirmed by a thiamine level below the detection limit (<5 ng>/mL). Although follow-up MRI showed radiological improvement after seven days, neurological recovery remained minimal despite 35 days of treatment. Nonspecific clinical manifestation of NAWE makes early diagnosis difficult, often resulting in progression to more advanced stages with cortical lesions. To prevent irreversible and potentially fatal neurological sequelae, it is crucial to be aware of NAWE in its early stages, particularly in patients with known risk factors, such as malnutrition (poor nutritional intake), parenteral nutrition without thiamine, gastric bypass surgery, malabsorption, dialysis, diuretic use, infections/sepsis, and hyperthyroidism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.